Thrombopoietic agents for the treatment of persistent and chronic immune thrombocytopenia in children

Journal of Pediatrics

Volumn 165, Issue 3, 2014, Pages

  Ramaswamy, Kavitha ^a   Hsieh, Loan ^b   Leven, Emily ^a   Thompson, Michaela V ^a   Nugent, Diane ^b   Bussel, James B ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELTROMBOPAG; ROMIPLOSTIM; THROMBOPOIETIN; BENZOIC ACID DERIVATIVE; FC RECEPTOR; HYBRID PROTEIN; HYDRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADOLESCENT; ADULT; ANKLE FRACTURE; ARTICLE; BONE MARROW; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE THROMBOCYTOPENIA; MYELOFIBROSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; FEMALE; MALE; PRESCHOOL CHILD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; BENZOATES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; HYDRAZINES; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRAZOLES; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; THROMBOPOIETIN; YOUNG ADULT;

EID: 84906940330     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.03.060     Document Type: Article

References (22)

1. J.B. Bussel, D.J. Kuter, J.N. George, R. McMillan, L.M. Aledort, and G.T. Conklin et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP N Engl J Med 355 2006 1672 1681
2. J.B. Bussel, G. Cheng, M.N. Saleh, B. Psaila, L. Kovaleva, and B. Meddeb et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura N Engl J Med 357 2007 2237 2247
3. D.J. Kuter, J.B. Bussel, R.M. Lyons, V. Pullarkat, T.B. Gernsheimer, and F.M. Senecal et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind, randomised controlled trial Lancet 371 2008 395 403
4. J.B. Bussel, D. Provan, T. Shamsi, G. Cheg, B. Psaila, and L. Kovaleva et al. Effect of Eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial Lancet 373 2009 641 648
5. D.J. Kuter, M. Rummel, R. Boccia, B.G. Macik, I. Pabinger, and D. Selleslag et al. Romiplostim or standard of care in patients with immune thrombocytopenia N Engl J Med 363 2010 1889 1899
6. G. Cheng, M.N. Saleh, C. Marcher, S. Vasey, B. Mayer, and M. Aivado et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study Lancet 377 2011 393 402
7. D.J. Kuter, J.B. Bussel, A. Newland, R.I. Baker, R.M. Lyons, and J. Wasser et al. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy Br J Haematol 161 2013 411 423
8. M.N. Saleh, J.B. Bussel, G. Cheng, O. Meyer, C.K. Bailey, and M. Arning et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study Blood 121 2013 537 545
9. J.B. Bussel, D.J. Kuter, V. Pullarkat, R.M. Lyons, M. Guo, and J.L. Nichol Safety and efficacy of long-term treatment with Romiplostim in thrombocytopenic patients with chronic ITP Blood 113 2009 2161 2171
10. J.B. Bussel, G.R. Buchanan, D.J. Nugent, D.J. Gnarra, L.R. Bomgaars, and V.S. Blanchette et al. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia Blood 118 2011 28 36
11. R.J. Klaassen, S.D. Mathias, G. Buchanan, J. Bussel, R. Deuson, and N.L. Young et al. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP) Pediatr Blood Cancer 58 2012 395 398
12. G.M. Mokhtar, A.A. Tantawy, and N.H. El Sherif Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia Platelets 23 2012 264 273
13. J. Thiele, H.M. Kvasnicka, F. Facchetti, V. Franco, J. van der Walt, and A. Orazi European consensus on grading bone marrow fibrosis and assessment of cellularity Haematologica 90 2005 1128 1132
14. D.J. Kuter, G.J. Mufti, B.J. Bain, R.P. Hasserjian, W. Davis, and M. Rutstein Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with Romiplostim Blood 114 2009 3748 3756
15. P.F. Fogarty, M.D. Tarantino, A. Brainsky, J. Signorovitch, and K. Grotzinger Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia Curr Med Res Opin 28 2012 79 87
16. C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg, and M.A. Crowther The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Blood 117 2011 4190 4207
17. J. Bussel, J. Grainger, J. Despotovic, V. Blanchette, P. Connor, and T. Biss et al. Eltrombopag for the treatment of childhood chronic ITP: The PETIT study, a placebo-controlled clinical trial Haematologica 97 2012 501
18. C. McGuinn, A. Imahiyerobo, M.V. Thompson, N. Haq, C. Tchatchouang, and J.B. Bussel Safety and efficacy of eltrombopag at escalated doses up to 150 mg in patients with persistent and chronic immune thrombocytopenia (ITP) not responsive To 75 mg Blood 311 2013 3559
19. M. Khellaf, J.F. Viallard, M. Hamidou, S. Cheze, F. Roudot-Thoraval, and B. Godeau et al. A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia Haemetalogica 98 2013 881 887
20. A. Newland, L. Cervinek, J. Eggermann, F. Lefrere, and G. Kreuzbauer Sustained hemostatic platelet counts in adult patients with primary immune thrombocytopenia (ITP) following cessation of romipolostim - four European case studies Haematologica 96 2011 98
21. J.B. Bussel, F. Rodeghiero, R.M. Lyons, B. Firstenberg, J. Joseph, and C.M. Kessler et al. Sustained hemostatic platelet counts in adults with immune thrombocytopenia (ITP) following cessation of treatment with the tpo receptor agonist romiplostim: report of 9 cases Blood 118 2011 3281
22. E. Leven, A. Miller, N. Boulad, A. Haider, and J.B. Bussel Successful discontinuation of eltrombopag treatment in patients with chronic ITP Blood 120 2012 1085